291 related articles for article (PubMed ID: 10769112)
1. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.
Vaisman A; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2000 Apr; 39(16):4575-80. PubMed ID: 10769112
[TBL] [Abstract][Full Text] [Related]
2. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
Bassett E; Vaisman A; Havener JM; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2003 Dec; 42(48):14197-206. PubMed ID: 14640687
[TBL] [Abstract][Full Text] [Related]
3. Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.
Bassett E; Vaisman A; Tropea KA; McCall CM; Masutani C; Hanaoka F; Chaney SG
DNA Repair (Amst); 2002 Dec; 1(12):1003-16. PubMed ID: 12531010
[TBL] [Abstract][Full Text] [Related]
4. Protein interactions with platinum-DNA adducts: from structure to function.
Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
[TBL] [Abstract][Full Text] [Related]
5. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.
Chaney SG; Campbell SL; Bassett E; Wu Y
Crit Rev Oncol Hematol; 2005 Jan; 53(1):3-11. PubMed ID: 15607931
[TBL] [Abstract][Full Text] [Related]
6. Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts.
Vaisman A; Lim SE; Patrick SM; Copeland WC; Hinkle DC; Turchi JJ; Chaney SG
Biochemistry; 1999 Aug; 38(34):11026-39. PubMed ID: 10460158
[TBL] [Abstract][Full Text] [Related]
7. The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta.
Vaisman A; Chaney SG
J Biol Chem; 2000 Apr; 275(17):13017-25. PubMed ID: 10777605
[TBL] [Abstract][Full Text] [Related]
8. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts.
Bassett E; King NM; Bryant MF; Hector S; Pendyala L; Chaney SG; Cordeiro-Stone M
Cancer Res; 2004 Sep; 64(18):6469-75. PubMed ID: 15374956
[TBL] [Abstract][Full Text] [Related]
9. Specificity of platinum-DNA adduct repair.
Chaney SG; Vaisman A
J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
[TBL] [Abstract][Full Text] [Related]
10. Translesion synthesis past platinum DNA adducts by human DNA polymerase mu.
Havener JM; Nick McElhinny SA; Bassett E; Gauger M; Ramsden DA; Chaney SG
Biochemistry; 2003 Feb; 42(6):1777-88. PubMed ID: 12578393
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for the bypass of the major oxaliplatin-DNA adducts by human DNA polymerase η.
Ouzon-Shubeita H; Baker M; Koag MC; Lee S
Biochem J; 2019 Feb; 476(4):747-758. PubMed ID: 30709915
[TBL] [Abstract][Full Text] [Related]
12. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I
Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866
[TBL] [Abstract][Full Text] [Related]
13. Translesion Synthesis of the N(2)-2'-Deoxyguanosine Adduct of the Dietary Mutagen IQ in Human Cells: Error-Free Replication by DNA Polymerase κ and Mutagenic Bypass by DNA Polymerases η, ζ, and Rev1.
Bose A; Millsap AD; DeLeon A; Rizzo CJ; Basu AK
Chem Res Toxicol; 2016 Sep; 29(9):1549-59. PubMed ID: 27490094
[TBL] [Abstract][Full Text] [Related]
14. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta.
Alt A; Lammens K; Chiocchini C; Lammens A; Pieck JC; Kuch D; Hopfner KP; Carell T
Science; 2007 Nov; 318(5852):967-70. PubMed ID: 17991862
[TBL] [Abstract][Full Text] [Related]
15. DNA binding properties of human DNA polymerase eta: implications for fidelity and polymerase switching of translesion synthesis.
Kusumoto R; Masutani C; Shimmyo S; Iwai S; Hanaoka F
Genes Cells; 2004 Dec; 9(12):1139-50. PubMed ID: 15569147
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of accurate translesion synthesis by human DNA polymerase eta.
Masutani C; Kusumoto R; Iwai S; Hanaoka F
EMBO J; 2000 Jun; 19(12):3100-9. PubMed ID: 10856253
[TBL] [Abstract][Full Text] [Related]
17. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.
Comess KM; Burstyn JN; Essigmann JM; Lippard SJ
Biochemistry; 1992 Apr; 31(16):3975-90. PubMed ID: 1314653
[TBL] [Abstract][Full Text] [Related]
18. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage.
Albertella MR; Green CM; Lehmann AR; O'Connor MJ
Cancer Res; 2005 Nov; 65(21):9799-806. PubMed ID: 16267001
[TBL] [Abstract][Full Text] [Related]
19. Sequence context-dependent replication of DNA templates containing UV-induced lesions by human DNA polymerase iota.
Vaisman A; Frank EG; Iwai S; Ohashi E; Ohmori H; Hanaoka F; Woodgate R
DNA Repair (Amst); 2003 Sep; 2(9):991-1006. PubMed ID: 12967656
[TBL] [Abstract][Full Text] [Related]
20. Miscoding properties of 2'-deoxyinosine, a nitric oxide-derived DNA Adduct, during translesion synthesis catalyzed by human DNA polymerases.
Yasui M; Suenaga E; Koyama N; Masutani C; Hanaoka F; Gruz P; Shibutani S; Nohmi T; Hayashi M; Honma M
J Mol Biol; 2008 Apr; 377(4):1015-23. PubMed ID: 18304575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
